- Clinical Effects of Gemifloxacin on the Delay of Tuberculosis Treatment
-
Kim SY, Yim JJ, Park JS, Park SS, Heo EY, Lee CH, Chung HS, Kim DK
- KMID: 1786934
- J Korean Med Sci.
- 2013 Mar;28(3):378-382.
- doi: 10.3346/jkms.2013.28.3.378
Although gemifloxacin has low in vitro activity against Mycobacterium tuberculosis, the effect of gemifloxacin on the delay of tuberculosis (TB) treatment has not been validated in a clinical setting. The... -
- CITED
-
- Close
- SHARE
-
- Close
- In vitro Activity of Gemifloxacin Against Recent Clinical Isolates of Bacteria in Korea
-
Yong DE, Cheong HJ, Kim YS, Park YJ, Kim WJ, Woo JH, Lee KW, Kang MW, Choo YS
- KMID: 648780
- J Korean Med Sci.
- 2002 Dec;17(6):737-742.
- doi: 10.3346/jkms.2002.17.6.737
Gemifloxacin is an enhanced-affinity fluoroquinolone with broad-spectrum antibacterial activity. In Korea, resistant bacteria are relatively more prevalent than in other industrialized countries. In this study, we studied the in... -
- CITED
-
- Close
- SHARE
-
- Close
